糖尿病对下肢血运重建外周动脉疾病患者临床结局的影响:系统评价与荟萃分析
该系统评价与荟萃分析检索6个数据库至2024年2月,纳入11项观察性研究共139,497例下肢血运重建患者,其中44.8%合并糖尿病。糖尿病与30天再入院(RR 1.28)、30天大截肢(RR 1.31)和30天伤口感染(RR 1.32)风险增加相关,与30天死亡率无显著关联(RR 1.08,95%CI 0.93-1.24)。
要点
- 糖尿病与下肢血运重建后30天再入院风险增加相关(RR 1.28,95%CI 1.20-1.37)。
- 糖尿病与30天大截肢风险增加相关(RR 1.31,95%CI 1.14-1.50,I²=86%)。
- 糖尿病与30天伤口感染风险增加相关(RR 1.32,95%CI 1.11-1.56,I²=81%)。
核心结论
- 糖尿病与下肢血运重建后30天大截肢、再入院和伤口感染风险增加相关,但不影响30天死亡风险。
研究设计与样本
- 系统评价与荟萃分析,检索Cochrane Library、Embase、Google Scholar、Medline、Scopus和Web of Science共6个数据库至2024年2月,纳入11项观察性研究共139,497例下肢血运重建患者,其中44.8%合并糖尿病。
主要发现
- 糖尿病与30天再入院风险增加相关(RR 1.28,95%CI 1.20-1.37,I²=28%,P<.001)。
- 糖尿病与30天大截肢风险增加相关(RR 1.31,95%CI 1.14-1.50,I²=86%,P<.001)。
- 糖尿病与30天伤口感染风险增加相关(RR 1.32,95%CI 1.11-1.56,I²=81%,P=.001)。
- 糖尿病与30天死亡率无显著关联(RR 1.08,95%CI 0.93-1.24,I²=65%,P=.33)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Peripheral arterial disease is highly prevalent and has a well-established association with diabetes mellitus (DM). However, it remains unclear whether DM worsens clinical outcomes after lower extremity revascularization (LER). METHODS: We performed a systematic search of six databases (Cochrane Library, Embase, Google Scholar, Medline, Scopus, and Web of Science) through February 2024, including studies that reported a risk estimate for the association of DM with 30-day all-cause mortality, hospital readmission, major amputation, and wound infection for patients following LER. For each outcome, a random-effect meta-analysis was applied to pool the relative risk (RR) estimates across studies. I2 statistics were used to examine heterogeneity. RESULTS: Of the 3079 articles screened, 11 observational studies with 139,497 patients were included. A total of 44.8% of patients had DM. DM was associated with an increased risk of 30-day hospital readmission (RR, 1.28; 95% confidence interval (CI), 1.20-1.37; I2 = 28%; P < .001), 30-day major limb amputation (RR, 1.31; 95% CI, 1.14-1.50; I2 = 86%; P < .001), and 30-day wound infection (RR, 1.32; 95% CI, 1.11-1.56; I2 = 81%; P = .001). There was no significant association between DM and 30-day mortality (RR, 1.08; 95% CI, 0.93-1.24; I2 = 65%; P = .33). CONCLUSIONS: Our findings suggest that DM is associated with an increased risk of major amputation, readmission, and wound infection risk, but does not affect mortality risk in patients 30 days after LER.
引用
- Edjimbi JAC, Shah N, Kwaah PA, et al. Effect of diabetes on clinical outcomes in patients with peripheral arterial disease undergoing lower extremity revascularization: A systematic review and meta-analysis. J Vasc Surg. 2025. PMID: 40015609. doi:10.1016/j.jvs.2025.02.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。